Brainomix specializes in the creation of AI-powered software solutions to enable precision medicine for better treatment decisions in #stroke and #lung fibrosis
#ATS2026 is just over a week away, and we're excited to connect with everyone in sunny Orlando! ☀️ You won't want to miss these two exciting e-Lung sessions we have. Be sure to stop by the Brainomix booth (#2250) to meet our team and see e-Lung in action.🫁
@atscommunity
📣 Brainomix and @Boehringer Advance Strategic Partnership in Pulmonary Fibrosis
🚀We’re expanding our partnership after strong early results for e-Lung in earlier PPF diagnosis. Next: PROGRESS PPF, a multicenter US study evaluating impact at scale.
https://t.co/JAr86Ush35
📣 Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion
Additional funding will enhance Brainomix's industry-leading customer support and fast-track product advancements across its stroke and lung AI imaging platforms.
https://t.co/6hQlyT6Keo
🔬Brainomix e-Lung AI Imaging Technology Selected as Co-Primary Endpoint in @Boehringer Ingelheim Phase 3 Clinical Trial in Pulmonary Fibrosis🫁
Learn more about the DROP-FPF study ⤵️
https://t.co/No4sfrRXKT
📣 @LancetDigitalH Study: Brainomix 360 Stroke Increases Thrombectomy Rates. The largest real-world evaluation of stroke AI, with data from more than 450,000 patients over a 5-year period, showed a 100% increase in thrombectomy at Brainomix sites. https://t.co/10M1ZhueYm
🏆Brainomix were named winners this weekend at the @American_Heart Association's Health Tech Competition at Scientific Sessions 2025 in New Orleans, winning the top Science award.
Learn more⤵️
https://t.co/F16Swc40n8
We're headed to Chicago this week to attend the #PFFSummit, the world's largest conference focused on pulmonary fibrosis. We look forward to connecting with patients, clinicians, and industry partners, to share the exciting progress we are making with our e-Lung technology.
We're proud to be recognized as a #Finalist in the @American_Heart Health Tech Competition! Our AI enabled imaging solutions are helping improve patient outcomes and expand access to life-saving treatment. #AHAInnovation#CHTI#HealthTech
👇Take a moment to watch this interview with @DrPeter_George, who discusses e-Lung results from REVISE PPF that were recently presented at #CHEST2025, indicating a potential to support earlier #PPF diagnosis.
📣Brainomix e-Lung Enables Earlier Detection of Progressive Pulmonary Fibrosis (PPF), New Study Shows
New evidence presented at #CHEST2025 shows e-Lung could have significantly accelerated the diagnosis of PPF in over half of patients by up to almost 2 years. Read more 👇
Headed to Chicago for #CHEST2025? Stop by our booth to learn more about e-Lung and the exciting REVISE PPF results, showing the potential for e-Lung to accelerate PPF diagnosis by nearly 2 years. #VisionToPrecision@DrPeter_George
Headed to #ERS2025? Be sure to catch @drdayjee present powerful new results from REVISE PPF:
✅ e-Lung accelerated PPF diagnosis in 62% of patients and up to 21 months earlier
✅ e-Lung was shown to be a robust, independent predictor of mortality
#PPF#ILD#eLung#REVISE
Brainomix is featured this week in @theLDNstandard ScaleUp and by @YahooFinance, highlighting the life-saving breakthroughs that we are driving globally. Read @lucytobin's full article below⤵️
https://t.co/6UDj5sLbyA
Headed to #SNIS2025 in Nashville? Be sure to stop by the #Brainomix booth to see how our technology is elevating stroke AI to a new level. See More. Do More. Save More. #TransformingTreatment
📢New Study Published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes Journal, demonstrating "a clear trend towards increased treatment rates of ischemic stroke and faster treatment times." Learn more⬇️
🔗https://t.co/UxaxND63OD
📺Yesterday's webinar provided a fascinating overivew of the cutting-edge research that Brainomix are spearheading, exploring the value of novel biomarkers to assess Brain Frailty and Net Water Uptake. ICYMI, be sure to watch the full recording here⬇️
https://t.co/xBythyXCv9